Studies focusing on aspects of nesfatin-1 and insulin resistance revealed that serum nesfatin-1 levels were decreased in insulin resistance-associated polycystic ovarian syndrome (59) and non-alcoholic fatty liver disease (60). This evidence concerns the gene NUCB2 and polycystic ovary syndrome.